Kingfisher PLC announced on 19 February 2026 that it purchased 25,000 ordinary shares for cancellation on 18 February 2026 from Goldman Sachs International at a volume-weighted average price of £3.6104 per share, with the highest price paid being £3.6380 and the lowest £3.5980. This transaction is part of the Company's £300 million share repurchase programme initiated on 25 March 2025. To date, Kingfisher has acquired 18,913,200 shares under the fifth tranche of this programme.
Kingfisher plc, ISIN: GB0033195214 (the "Company", "Kingfisher") announces that on 18 February 2026 it purchased for cancellation the following number of ordinary shares of 15 5/7 pence each from Goldman Sachs International ("GSI") as part of its £300 million share repurchase programme announced on 25 March 2025 (the "Programme"). All shares were purchased by Kingfisher from GSI as an "on-exchange" transaction subject to the rules of the London Stock Exchange.
Date of Purchase:
18 February 2026
Total number of shares purchased:
25,000
Volume Weighted Average price paid per share:
£3.6104
Highest price paid per share:
£3.6380
Lowest price paid per share:
£3.5980
To date, Kingfisher has purchased 18,913,200 ordinary shares in aggregate for cancellation from GSI in connection with the fifth tranche of the Programme. Kingfisher also previously purchased 17,932,871 ordinary shares in aggregate for cancellation from GSI,18,118,306 ordinary shares in aggregate for cancellation from BNP Paribas SA, 24,713,988 ordinary shares in aggregate for cancellation from GSI and 16,095,884 ordinary shares in aggregate for cancellation from Morgan Stanley & Co. International Plc in connection with its execution of the first, second, third and fourth tranches, respectively, of the Programme.
A schedule of individual trades carried out by GSI as principal in connection with the above purchases is set out below.
Schedule of Purchases - Aggregate Information
Trading Venue
Number of Shares
Volume Weighted Average Price paid per share
XLON
25,000
£3.6104
CHIX
0
£0.0000
BATE
0
£0.0000
TRQX
0
£0.0000
AQXE
0
£0.0000
Schedule of Purchases - Individual Transactions
Price GBP
Time of each trade on 18 Feb 2026 (GMT)
Trading Venue
Number of Shares
Transaction Reference Number
3.6250
08:41:36
XLON
1,219
1392282980851829
3.6230
08:43:08
XLON
1,265
1392282980852018
3.6210
09:11:35
XLON
1,017
1392282980854956
3.6260
09:39:05
XLON
1,061
1392282980857179
3.6380
10:08:50
XLON
1,011
1392282980859416
3.6250
10:35:15
XLON
881
1392282980861433
3.6080
11:05:35
XLON
996
1392282980863736
3.6030
11:41:04
XLON
998
1392282980865788
3.6020
12:08:41
XLON
1,080
1392282980867936
3.6010
12:37:08
XLON
971
1392282980869820
3.6010
13:16:02
XLON
1,040
1392282980872307
3.6030
13:51:29
XLON
922
1392282980875409
3.6020
13:57:26
XLON
921
1392282980875978
3.6060
14:18:18
XLON
930
1392282980877997
3.6040
14:32:03
XLON
993
1392282980882071
3.5980
14:44:09
XLON
958
1392282980886567
3.6020
14:55:36
XLON
450
1392282980890081
3.6040
14:58:11
XLON
62
1392282980890601
3.6040
14:58:14
XLON
939
1392282980890603
3.6080
15:10:31
XLON
953
1392282980894095
3.6130
15:20:03
XLON
942
1392282980896797
3.6140
15:37:06
XLON
1,037
1392282980901233
3.6150
15:54:11
XLON
1,105
1392282980905778
3.6080
16:05:04
XLON
922
1392282980909739
3.6010
16:15:49
XLON
944
1392282980913290
3.6010
16:25:30
XLON
1,014
1392282980916983
3.5990
16:26:45
XLON
369
1392282980917644
Contacts:
Tel:
Email:
Group Company Secretariat
+44 (0) 20 7372 8008
secretariat@kingfisher.com
Investor Relations
+44 (0) 20 7644 1082
investorenquiries@kingfisher.com
Treasury
+44 (0) 20 7372 8008
treasury@kingfisher.com
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
AI Summary Disclaimer BETA
The content you are viewing has been generated or assisted by artificial
intelligence (AI). While efforts are made to ensure accuracy and clarity, AI-generated text may
contain inaccuracies, outdated information, or subjective interpretations. This content is intended
for general informational purposes only and should not be considered professional advice or factual
confirmation.
We encourage you to independently verify any information provided,
especially if it will be relied upon for making decisions or taking action. Any reliance you place
on this material is strictly at your own risk. The AI system that produced this content cannot
assess the specifics of individual circumstances, and results may vary based on context and
individual needs.
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.
Create an Account
Create your FREE account to receive personalised announcements, watchlists, market updates, investment insights and new features.
Personalise your experience
Tell us a little about yourself to receive personalised content, announcements and relevant investment opportunities.
